- Moderna Inc. CEO Stéphane Bancel defended the company's pricing plans for its Covid-19 vaccine at Monday's Wall Street Journal Health Forum.
- Moderna received funding from the U.S. government related to development of the vaccine, but all capital risk was put in place by shareholders.
- Moderna plans to charge $110 - $130 per dose in the U.S. when it shifts to commercial distribution and individuals will not have to pay.
- The company's first supply of vaccine with the U.S. government in 2020 totaled 100 million doses and roughly $1.5 billion.
- Pfizer Inc. is considering a similar pricing range for its Covid-19 vaccine.
Moderna CEO Defends Pricing Plans for Covid-19 Shot
Stéphane Bancel says investors funded the mRNA vaccine platform